E-LIB Suche - Ergebnisse für: Rosenthal, Norm

1

Sodium‐glucose co‐transporter‐2 inhibition and ocular outco..:

Li, Chao ; Zhou, Zien ; Neuen, Brendon L....
Diabetes, Obesity and Metabolism. 23 (2020) 1 - p. 252-257 , 2020

Link: https://doi.org/10.1111/..

2

Comment on "Comparative effectiveness of canagliflozin, SGL..:

Ryan, Patrick B. ; Rosenthal, Norm
Diabetes, Obesity and Metabolism. 21 (2018) 2 - p. 444-445 , 2018

Link: https://doi.org/10.1111/..

3

Optimizing the analysis strategy for the CANVAS Program: A ..:

Neal, Bruce ; Perkovic, Vlado ; Mahaffey, Kenneth W....
Diabetes, Obesity and Metabolism. 19 (2017) 7 - p. 926-935 , 2017

Link: https://doi.org/10.1111/..

4

Comment on: Sodium‐glucose co‐transporter‐2 inhibitors and ..:

Canovatchel, William ; Davidson, Jennifer ; Rosenthal, Norm
Diabetes, Obesity and Metabolism. 19 (2017) 12 - p. 1823-1823 , 2017

Link: https://doi.org/10.1111/..

5

Renal safety of canagliflozin, a sodium glucose co‐transpor..:

Desai, Mehul ; Yavin, Yshai ; Balis, Dainius...
Diabetes, Obesity and Metabolism. 19 (2017) 6 - p. 897-900 , 2017

Link: https://doi.org/10.1111/..

6

Risk of lower extremity amputations in people with type 2 d..:

Yuan, Zhong ; DeFalco, Frank J. ; Ryan, Patrick B....
Diabetes, Obesity and Metabolism. 20 (2017) 3 - p. 582-589 , 2017

Link: https://doi.org/10.1111/..

7

Evaluation of Bone Mineral Density and Bone Biomarkers in P..:

Bilezikian, John P. ; Watts, Nelson B. ; Usiskin, Keith...
The Journal of Clinical Endocrinology & Metabolism. 101 (2016) 1 - p. 44-51 , 2016

Link: https://doi.org/10.1210/..

8

Canagliflozin: a sodium glucose co‐transporter 2 inhibitor ..:

Rosenthal, Norm ; Meininger, Gary ; Ways, Kirk...
Annals of the New York Academy of Sciences. 1358 (2015) 1 - p. 28-43 , 2015

Link: https://doi.org/10.1111/..

9

Cardiovascular and Renal Outcomes With Canagliflozin Accord..:

Neuen, Brendon L ; Ohkuma, Toshiaki ; Neal, Bruce...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6181277/. , 2018

Link: http://www.ncbi.nlm.nih...

10

Cardiovascular and Renal Outcomes With Canagliflozin Accord..:

Neuen, Brendon L ; Ohkuma, Toshiaki ; Neal, Bruce...
https://research.rug.nl/en/publications/491b8929-f047-4a62-9daf-211568e73532. , 2018

Link: https://hdl.handle.net/1..

11

Optimizing the analysis strategy for the CANVAS Program: A ..:

Neal, Bruce ; Perkovic, Vlado ; Mahaffey, Kenneth W...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485085/. , 2017

Link: http://www.ncbi.nlm.nih...

12

Risk of lower extremity amputations in people with type 2 d..:

Yuan, Zhong ; DeFalco, Frank J ; Ryan, Patrick B...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836890/. , 2017

Link: http://www.ncbi.nlm.nih...

13

Renal safety of canagliflozin, a sodium glucose co‐transpor..:

Desai, Mehul ; Yavin, Yshai ; Balis, Dainius...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485046/. , 2017

Link: http://www.ncbi.nlm.nih...

14

Evaluation of Bone Mineral Density and Bone Biomarkers in P..:

Bilezikian, John P ; Watts, Nelson B ; Usiskin, Keith...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4701848/. , 2016

Link: http://www.ncbi.nlm.nih...

15

Why pharmacists should care about the marketing of unhealth..:

Houle, Sherilyn K. D. ; Rosenthal, Meagen M. ; Campbell, Norm R. C...
Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 147 (2014) 1 - p. 4-7 , 2014

Link: https://doi.org/10.1177/..